Drug Database
Back to search

Poland· PL-100324030

Moloxin

A moxifloxacin product containing moxifloxacinum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 16 of our 19 countries.

ATC J01MA14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMoloxinATCJ01MA14REGISTER NO.PL-100324030PACKS LISTED12CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about moxifloxacinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Moxifloxacin is registered in 16 of 19 countries.

Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search moxifloxacin products by name

Moxifloxacin · ATC J01MA14

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxifloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Moxifloxacin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.89
  • IT Italy$1.99
  • US United States$1.34 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Moxifloxacinum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
J01MA14
ATC class
Moxifloxacin
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

  • gtin
    05909991186166
  • gtin
    05909991186173
  • gtin
    05909991186180
  • gtin
    05909991186197
  • gtin
    05909991186210
  • gtin
    05909991186227
  • gtin
    05909991186234
  • gtin
    05909991186241
  • gtin
    05909991186258
  • gtin
    05909991186265
  • gtin
    05909991186272
  • gtin
    05909991186203

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

531 interactions on record for moxifloxacin.

Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check moxifloxacin against other medicinesHow interaction checks work

Moxifloxacin · interactions on record

531 records

  • 175 severe
  • 140 moderate
  • 49 minor
  • 92 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

75 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Moxifloxacin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxifloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Avelox, Moxifloxacin 1a Pharma
  • Belgium · Avelox, Kanavig
  • Bulgaria · Cimocinox, Moxifloxacin Kabi
  • Cyprus · Avelox, Erelan
  • Czechia · Avelox, Moxifloxacin Brown & Burk
  • Germany · Avalox, Moxifloxacin 1 A Pharma
  • Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
  • Estonia · Avelox, Floxelan
  • Spain · Abimox, Actira
  • Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
  • France · Izilox, Moxifloxacine Arrow
  • United Kingdom (Northern Ireland) · Avelox, Moxidox
  • Greece · Avelox, Mikrobiel
  • Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
  • Hungary · Moxibiot, Moxifloxacin Anfarm
  • Ireland · Moxifloxacin
  • Iceland · Vigamox
  • Italy · Avalox, Moxidrop
  • Lithuania · Avelox, Ekara
  • Luxembourg · Avelox, Kanavig
  • Latvia · Avelox, Ekara
  • Malta · Erelan, Moxifloxacin Anfarm
  • Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
  • Norway · Xinaflox
  • Portugal · Avelox, Bluesar
  • Romania · Avelox, Kimoks
  • Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
  • Slovenia · Kimoks, Moksifloksacin Kabi
  • Slovakia · Avelox, Moloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0d67ff8-cd57-4070-954b-0ec35f18aa23
GET /v1/drugs/d0d67ff8-cd57-4070-954b-0ec35f18aa23?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909991186166 ¦ Rp ¦ 103354\n70 tabl.\n05909991186173 ¦ Rp ¦ 103355\n28 tabl.\n05909991186180 ¦ Rp ¦ 103356\n10 tabl.\n05909991186197 ¦ Rp ¦ 103357\n25 tabl.\n05909991186203 ¦ Rp ¦ 103358\n14 tabl.\n05909991186210 ¦ Rp ¦ 103359\n120 tabl.\n05909991186227 ¦ Rp ¦ 103360\n7 tabl.\n05909991186234 ¦ Rp ¦ 103361\n100 tabl.\n05909991186241 ¦ Rp ¦ 103362\n50 tabl.\n05909991186258 ¦ Rp ¦ 103363\n5 tabl.\n05909991186265 ¦ Rp ¦ 103364\n80 tabl.\n05909991186272 ¦ Rp ¦ 103365\n30 tabl.",
  "substance": "Moxifloxacini hydrochloridum 454.75 mg",
  "common_name": "Moxifloxacinum",
  "pl_product_id": "100324030",
  "pozwolenie_nr": "22006",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about moxifloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console